Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat.

The present study was undertaken to determine if estrogens protect female rats from the neurodegenerative effects of middle cerebral artery (MCA) occlusion. The rats were ovariectomized and 7 or 8 days later various estrogen preparations were administered before or after MCA occlusion. Pretreatment with 17beta-estradiol (17beta-E2) or a brain-targeted 17beta-E2 chemical delivery system (CDS) decreased mortality from 65% in ovariectomized rats to 22% in 17beta-E2-treated and 16% in 17beta-E2 CDS-treated rats. This marked reduction in mortality was accompanied by a reduction in the ischemic area of the brain from 25.6+/-5.7% in the ovariectomized rats to 9.8+/-4% and 9.1+/-4.2% in the 17beta-E2-implanted and the 17beta-E2 CDS-treated rats, respectively. Similarly, pretreatment with the presumed inactive estrogen, 17alpha-estradiol, reduced mortality from 36 to 0% and reduced the ischemic area by 55 to 81%. When administered 40 or 90 minutes after MCA occlusion, 17beta-E2 CDS reduced the area of ischemia by 45 to 90% or 31%, respectively. In summary, the present study provides the first evidence that estrogens exert neuroprotective effects in an animal model of ischemia and suggests that estrogens may be a useful therapy to protect neurons against the neurodegenerative effects of stroke.

[1]  J. Simpkins,et al.  17α-Estradiol Exerts Neuroprotective Effects on SK-N-SH Cells , 1997, The Journal of Neuroscience.

[2]  A. Paganini-Hill.  Estrogen replacement therapy and stroke. , 1995, Progress in cardiovascular diseases.

[3]  D. Graham,et al.  Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion , 1985, Annals of neurology.

[4]  J. Simpkins,et al.  Estradiol Treatment Increases Viability of Glioma and Neuroblastoma Cells in Vitro , 1994, Molecular and Cellular Neuroscience.

[5]  M D Ginsberg,et al.  Rodent models of cerebral ischemia. , 1989, Stroke.

[6]  A. Betz,et al.  Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. , 1992, Neurosurgery.

[7]  J. Simpkins,et al.  The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease , 1994, Neurobiology of Aging.

[8]  J. Madans,et al.  Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. , 1993, Archives of internal medicine.

[9]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[10]  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. , 1991 .

[11]  E. Jensen,et al.  CHEMICAL STRUCTURE OF STEROIDS IN RELATION TO PROMOTION OF GROWTH OF THE VAGINA AND UTERUS OF THE HYPOPHYSECTOMIZED RAT , 1954, The Journal of experimental medicine.

[12]  P. H. Chan.  Oxygen Radicals in Focal Cerebral Ischemia , 1994, Brain pathology.

[13]  A. Hakim,et al.  Calcium‐Mediated Mechanisms of Ischemic Injury and Protection , 1994, Brain pathology.

[14]  D. Dorsa,et al.  Estrogen protects primary cortical neurons from glutamate neurotoxicity , 1996 .

[15]  D. Graham,et al.  Nimodipine and the Haemodynamic and Histopathological Consequences of Middle Cerebral Artery Occlusion in the Rat , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  A. Bostom,et al.  Postmenopausal estrogen therapy and cardiovascular disease. , 1992, The New England journal of medicine.

[17]  B. Psaty,et al.  Associations of Postmenopausal Estrogen Use With Cardiovascular Disease and Its Risk Factors in Older Women , 1993, Circulation.

[18]  N. Bodor,et al.  The potential use of cyclodextrins in parenteral formulations. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[19]  D. Choi.  Excitotoxic cell death. , 1992, Journal of neurobiology.

[20]  R. Traystman,et al.  Postischemic Cerebral Blood Flow Recovery in the Female: Effect of 17β-Estradiol , 1995 .

[21]  B. Henderson,et al.  Postmenopausal oestrogen treatment and stroke: a prospective study. , 1988, BMJ.

[22]  F. Holsboer,et al.  17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. , 1995, Biochemical and biophysical research communications.

[23]  M. Mattson,et al.  Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.

[24]  N. Bodor,et al.  The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues. I. Dose-response and time-course evaluation. , 1991, Endocrinology.

[25]  D. Choi,et al.  Excitotoxicity, free radicals, and cell membrane changes , 1994, Annals of neurology.

[26]  S. Korenman.  Comparative binding affinity of estrogens and its relation to estrogenic potency. , 1969, Steroids.

[27]  J. Simpkins,et al.  Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. , 1997, The American journal of medicine.

[28]  J. Simpkins,et al.  Estradiol protects against β-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells , 1996, Neuroscience Letters.

[29]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[30]  H. Adami,et al.  Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. , 1993, Archives of internal medicine.

[31]  W. Millard,et al.  Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats , 1994, Brain Research.

[32]  B. Wren.  The effect of oestrogen on the female cardiovascular system , 1992, The Medical journal of Australia.

[33]  N. Bodor,et al.  A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats. , 1987, Life sciences.

[34]  M. Williams,et al.  Effects of estradiol-17 alpha on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. , 1982, Journal of steroid biochemistry.

[35]  L. Brass,et al.  Middle cerebral artery blood velocity during controlled ovarian hyperstimulation. , 1992, Fertility and sterility.

[36]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[37]  N. Bodor,et al.  Brain-Targeted Delivery of Estrogens , 1990, Reviews in the neurosciences.